Global Anaplastic Thyroid Cancer Market Growth (Status and Outlook) 2025-2031

September 2025 | 74 pages | ID: G2A30AAEC0C0EN
LP Information

Abstracts

According to this study, the global Anaplastic Thyroid Cancer market size will reach US$ 4889 million by 2031.

Anaplastic thyroid cancer is one of four types ofthyroid cancer. It's very rare: The American ThyroidAssociation notes that this type represents less than 2 percent of all cases of thyroid cancer.

The anaplastic thyroid cancer therapeutics market is driven by the increasing incidence of anaplastic thyroid cancer and the urgent need for effective treatment options for this aggressive and rare form of thyroid cancer. Anaplastic thyroid cancer is associated with poor prognosis and limited treatment options, prompting researchers and pharmaceutical companies to explore novel therapeutic approaches. Advancements in targeted therapies, immunotherapies, and combination treatments are fueling market growth. However, challenges include the limited understanding of the disease's underlying mechanisms, the difficulty in diagnosing anaplastic thyroid cancer at an early stage, and the high cost of drug development and clinical trials. Overcoming these challenges through collaborative research, improved diagnostic methods, and accessible treatment options will be crucial for the sustained growth of the anaplastic thyroid cancer therapeutics market.

LPI (LP Information)' newest research report, the “Anaplastic Thyroid Cancer Industry Forecast” looks at past sales and reviews total world Anaplastic Thyroid Cancer sales in 2024, providing a comprehensive analysis by region and market sector of projected Anaplastic Thyroid Cancer sales for 2025 through 2031. With Anaplastic Thyroid Cancer sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Anaplastic Thyroid Cancer industry.

This Insight Report provides a comprehensive analysis of the global Anaplastic Thyroid Cancer landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Anaplastic Thyroid Cancer portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Anaplastic Thyroid Cancer market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Anaplastic Thyroid Cancer and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Anaplastic Thyroid Cancer.

This report presents a comprehensive overview, market shares, and growth opportunities of Anaplastic Thyroid Cancer market by product type, application, key players and key regions and countries.

Segmentation by Type:

• Oral
• Injection

Segmentation by Application:

• Hospital
• Drugs Store
• Other

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

• Novartis
• Sanofi Genzyme
• Bayer

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Anaplastic Thyroid Cancer Market Size (2020-2031)
  2.1.2 Anaplastic Thyroid Cancer Market Size CAGR by Region (2020 VS 2024 VS 2031)
  2.1.3 World Current & Future Analysis for Anaplastic Thyroid Cancer by Country/Region (2020, 2024 & 2031)
2.2 Anaplastic Thyroid Cancer Segment by Type
  2.2.1 Oral
  2.2.2 Injection
2.3 Anaplastic Thyroid Cancer Market Size by Type
  2.3.1 Anaplastic Thyroid Cancer Market Size CAGR by Type (2020 VS 2024 VS 2031)
  2.3.2 Global Anaplastic Thyroid Cancer Market Size Market Share by Type (2020-2025)
2.4 Anaplastic Thyroid Cancer Segment by Application
  2.4.1 Hospital
  2.4.2 Drugs Store
  2.4.3 Other
2.5 Anaplastic Thyroid Cancer Market Size by Application
  2.5.1 Anaplastic Thyroid Cancer Market Size CAGR by Application (2020 VS 2024 VS 2031)
  2.5.2 Global Anaplastic Thyroid Cancer Market Size Market Share by Application (2020-2025)

3 ANAPLASTIC THYROID CANCER MARKET SIZE BY PLAYER

3.1 Anaplastic Thyroid Cancer Market Size Market Share by Player
  3.1.1 Global Anaplastic Thyroid Cancer Revenue by Player (2020-2025)
  3.1.2 Global Anaplastic Thyroid Cancer Revenue Market Share by Player (2020-2025)
3.2 Global Anaplastic Thyroid Cancer Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 ANAPLASTIC THYROID CANCER BY REGION

4.1 Anaplastic Thyroid Cancer Market Size by Region (2020-2025)
4.2 Global Anaplastic Thyroid Cancer Annual Revenue by Country/Region (2020-2025)
4.3 Americas Anaplastic Thyroid Cancer Market Size Growth (2020-2025)
4.4 APAC Anaplastic Thyroid Cancer Market Size Growth (2020-2025)
4.5 Europe Anaplastic Thyroid Cancer Market Size Growth (2020-2025)
4.6 Middle East & Africa Anaplastic Thyroid Cancer Market Size Growth (2020-2025)

5 AMERICAS

5.1 Americas Anaplastic Thyroid Cancer Market Size by Country (2020-2025)
5.2 Americas Anaplastic Thyroid Cancer Market Size by Type (2020-2025)
5.3 Americas Anaplastic Thyroid Cancer Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Anaplastic Thyroid Cancer Market Size by Region (2020-2025)
6.2 APAC Anaplastic Thyroid Cancer Market Size by Type (2020-2025)
6.3 APAC Anaplastic Thyroid Cancer Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 EUROPE

7.1 Europe Anaplastic Thyroid Cancer Market Size by Country (2020-2025)
7.2 Europe Anaplastic Thyroid Cancer Market Size by Type (2020-2025)
7.3 Europe Anaplastic Thyroid Cancer Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Anaplastic Thyroid Cancer by Region (2020-2025)
8.2 Middle East & Africa Anaplastic Thyroid Cancer Market Size by Type (2020-2025)
8.3 Middle East & Africa Anaplastic Thyroid Cancer Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 GLOBAL ANAPLASTIC THYROID CANCER MARKET FORECAST

10.1 Global Anaplastic Thyroid Cancer Forecast by Region (2026-2031)
  10.1.1 Global Anaplastic Thyroid Cancer Forecast by Region (2026-2031)
  10.1.2 Americas Anaplastic Thyroid Cancer Forecast
  10.1.3 APAC Anaplastic Thyroid Cancer Forecast
  10.1.4 Europe Anaplastic Thyroid Cancer Forecast
  10.1.5 Middle East & Africa Anaplastic Thyroid Cancer Forecast
10.2 Americas Anaplastic Thyroid Cancer Forecast by Country (2026-2031)
  10.2.1 United States Market Anaplastic Thyroid Cancer Forecast
  10.2.2 Canada Market Anaplastic Thyroid Cancer Forecast
  10.2.3 Mexico Market Anaplastic Thyroid Cancer Forecast
  10.2.4 Brazil Market Anaplastic Thyroid Cancer Forecast
10.3 APAC Anaplastic Thyroid Cancer Forecast by Region (2026-2031)
  10.3.1 China Anaplastic Thyroid Cancer Market Forecast
  10.3.2 Japan Market Anaplastic Thyroid Cancer Forecast
  10.3.3 Korea Market Anaplastic Thyroid Cancer Forecast
  10.3.4 Southeast Asia Market Anaplastic Thyroid Cancer Forecast
  10.3.5 India Market Anaplastic Thyroid Cancer Forecast
  10.3.6 Australia Market Anaplastic Thyroid Cancer Forecast
10.4 Europe Anaplastic Thyroid Cancer Forecast by Country (2026-2031)
  10.4.1 Germany Market Anaplastic Thyroid Cancer Forecast
  10.4.2 France Market Anaplastic Thyroid Cancer Forecast
  10.4.3 UK Market Anaplastic Thyroid Cancer Forecast
  10.4.4 Italy Market Anaplastic Thyroid Cancer Forecast
  10.4.5 Russia Market Anaplastic Thyroid Cancer Forecast
10.5 Middle East & Africa Anaplastic Thyroid Cancer Forecast by Region (2026-2031)
  10.5.1 Egypt Market Anaplastic Thyroid Cancer Forecast
  10.5.2 South Africa Market Anaplastic Thyroid Cancer Forecast
  10.5.3 Israel Market Anaplastic Thyroid Cancer Forecast
  10.5.4 Turkey Market Anaplastic Thyroid Cancer Forecast
10.6 Global Anaplastic Thyroid Cancer Forecast by Type (2026-2031)
10.7 Global Anaplastic Thyroid Cancer Forecast by Application (2026-2031)
  10.7.1 GCC Countries Market Anaplastic Thyroid Cancer Forecast

11 KEY PLAYERS ANALYSIS

11.1 Novartis
  11.1.1 Novartis Company Information
  11.1.2 Novartis Anaplastic Thyroid Cancer Product Offered
  11.1.3 Novartis Anaplastic Thyroid Cancer Revenue, Gross Margin and Market Share (2020-2025)
  11.1.4 Novartis Main Business Overview
  11.1.5 Novartis Latest Developments
11.2 Sanofi Genzyme
  11.2.1 Sanofi Genzyme Company Information
  11.2.2 Sanofi Genzyme Anaplastic Thyroid Cancer Product Offered
  11.2.3 Sanofi Genzyme Anaplastic Thyroid Cancer Revenue, Gross Margin and Market Share (2020-2025)
  11.2.4 Sanofi Genzyme Main Business Overview
  11.2.5 Sanofi Genzyme Latest Developments
11.3 Bayer
  11.3.1 Bayer Company Information
  11.3.2 Bayer Anaplastic Thyroid Cancer Product Offered
  11.3.3 Bayer Anaplastic Thyroid Cancer Revenue, Gross Margin and Market Share (2020-2025)
  11.3.4 Bayer Main Business Overview
  11.3.5 Bayer Latest Developments

12 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Anaplastic Thyroid Cancer Market Size CAGR by Region (2020 VS 2024 VS 2031) & ($ millions)
Table 2. Anaplastic Thyroid Cancer Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Oral
Table 4. Major Players of Injection
Table 5. Anaplastic Thyroid Cancer Market Size CAGR by Type (2020 VS 2024 VS 2031) & ($ millions)
Table 6. Global Anaplastic Thyroid Cancer Market Size by Type (2020-2025) & ($ millions)
Table 7. Global Anaplastic Thyroid Cancer Market Size Market Share by Type (2020-2025)
Table 8. Anaplastic Thyroid Cancer Market Size CAGR by Application (2020 VS 2024 VS 2031) & ($ millions)
Table 9. Global Anaplastic Thyroid Cancer Market Size by Application (2020-2025) & ($ millions)
Table 10. Global Anaplastic Thyroid Cancer Market Size Market Share by Application (2020-2025)
Table 11. Global Anaplastic Thyroid Cancer Revenue by Player (2020-2025) & ($ millions)
Table 12. Global Anaplastic Thyroid Cancer Revenue Market Share by Player (2020-2025)
Table 13. Anaplastic Thyroid Cancer Key Players Head office and Products Offered
Table 14. Anaplastic Thyroid Cancer Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Anaplastic Thyroid Cancer Market Size by Region (2020-2025) & ($ millions)
Table 18. Global Anaplastic Thyroid Cancer Market Size Market Share by Region (2020-2025)
Table 19. Global Anaplastic Thyroid Cancer Revenue by Country/Region (2020-2025) & ($ millions)
Table 20. Global Anaplastic Thyroid Cancer Revenue Market Share by Country/Region (2020-2025)
Table 21. Americas Anaplastic Thyroid Cancer Market Size by Country (2020-2025) & ($ millions)
Table 22. Americas Anaplastic Thyroid Cancer Market Size Market Share by Country (2020-2025)
Table 23. Americas Anaplastic Thyroid Cancer Market Size by Type (2020-2025) & ($ millions)
Table 24. Americas Anaplastic Thyroid Cancer Market Size Market Share by Type (2020-2025)
Table 25. Americas Anaplastic Thyroid Cancer Market Size by Application (2020-2025) & ($ millions)
Table 26. Americas Anaplastic Thyroid Cancer Market Size Market Share by Application (2020-2025)
Table 27. APAC Anaplastic Thyroid Cancer Market Size by Region (2020-2025) & ($ millions)
Table 28. APAC Anaplastic Thyroid Cancer Market Size Market Share by Region (2020-2025)
Table 29. APAC Anaplastic Thyroid Cancer Market Size by Type (2020-2025) & ($ millions)
Table 30. APAC Anaplastic Thyroid Cancer Market Size by Application (2020-2025) & ($ millions)
Table 31. Europe Anaplastic Thyroid Cancer Market Size by Country (2020-2025) & ($ millions)
Table 32. Europe Anaplastic Thyroid Cancer Market Size Market Share by Country (2020-2025)
Table 33. Europe Anaplastic Thyroid Cancer Market Size by Type (2020-2025) & ($ millions)
Table 34. Europe Anaplastic Thyroid Cancer Market Size by Application (2020-2025) & ($ millions)
Table 35. Middle East & Africa Anaplastic Thyroid Cancer Market Size by Region (2020-2025) & ($ millions)
Table 36. Middle East & Africa Anaplastic Thyroid Cancer Market Size by Type (2020-2025) & ($ millions)
Table 37. Middle East & Africa Anaplastic Thyroid Cancer Market Size by Application (2020-2025) & ($ millions)
Table 38. Key Market Drivers & Growth Opportunities of Anaplastic Thyroid Cancer
Table 39. Key Market Challenges & Risks of Anaplastic Thyroid Cancer
Table 40. Key Industry Trends of Anaplastic Thyroid Cancer
Table 41. Global Anaplastic Thyroid Cancer Market Size Forecast by Region (2026-2031) & ($ millions)
Table 42. Global Anaplastic Thyroid Cancer Market Size Market Share Forecast by Region (2026-2031)
Table 43. Global Anaplastic Thyroid Cancer Market Size Forecast by Type (2026-2031) & ($ millions)
Table 44. Global Anaplastic Thyroid Cancer Market Size Forecast by Application (2026-2031) & ($ millions)
Table 45. Novartis Details, Company Type, Anaplastic Thyroid Cancer Area Served and Its Competitors
Table 46. Novartis Anaplastic Thyroid Cancer Product Offered
Table 47. Novartis Anaplastic Thyroid Cancer Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 48. Novartis Main Business
Table 49. Novartis Latest Developments
Table 50. Sanofi Genzyme Details, Company Type, Anaplastic Thyroid Cancer Area Served and Its Competitors
Table 51. Sanofi Genzyme Anaplastic Thyroid Cancer Product Offered
Table 52. Sanofi Genzyme Anaplastic Thyroid Cancer Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 53. Sanofi Genzyme Main Business
Table 54. Sanofi Genzyme Latest Developments
Table 55. Bayer Details, Company Type, Anaplastic Thyroid Cancer Area Served and Its Competitors
Table 56. Bayer Anaplastic Thyroid Cancer Product Offered
Table 57. Bayer Anaplastic Thyroid Cancer Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 58. Bayer Main Business
Table 59. Bayer Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Anaplastic Thyroid Cancer Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Anaplastic Thyroid Cancer Market Size Growth Rate (2020-2031) ($ millions)
Figure 6. Anaplastic Thyroid Cancer Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 7. Anaplastic Thyroid Cancer Sales Market Share by Country/Region (2024)
Figure 8. Anaplastic Thyroid Cancer Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 9. Global Anaplastic Thyroid Cancer Market Size Market Share by Type in 2024
Figure 10. Anaplastic Thyroid Cancer in Hospital
Figure 11. Global Anaplastic Thyroid Cancer Market: Hospital (2020-2025) & ($ millions)
Figure 12. Anaplastic Thyroid Cancer in Drugs Store
Figure 13. Global Anaplastic Thyroid Cancer Market: Drugs Store (2020-2025) & ($ millions)
Figure 14. Anaplastic Thyroid Cancer in Other
Figure 15. Global Anaplastic Thyroid Cancer Market: Other (2020-2025) & ($ millions)
Figure 16. Global Anaplastic Thyroid Cancer Market Size Market Share by Application in 2024
Figure 17. Global Anaplastic Thyroid Cancer Revenue Market Share by Player in 2024
Figure 18. Global Anaplastic Thyroid Cancer Market Size Market Share by Region (2020-2025)
Figure 19. Americas Anaplastic Thyroid Cancer Market Size 2020-2025 ($ millions)
Figure 20. APAC Anaplastic Thyroid Cancer Market Size 2020-2025 ($ millions)
Figure 21. Europe Anaplastic Thyroid Cancer Market Size 2020-2025 ($ millions)
Figure 22. Middle East & Africa Anaplastic Thyroid Cancer Market Size 2020-2025 ($ millions)
Figure 23. Americas Anaplastic Thyroid Cancer Value Market Share by Country in 2024
Figure 24. United States Anaplastic Thyroid Cancer Market Size Growth 2020-2025 ($ millions)
Figure 25. Canada Anaplastic Thyroid Cancer Market Size Growth 2020-2025 ($ millions)
Figure 26. Mexico Anaplastic Thyroid Cancer Market Size Growth 2020-2025 ($ millions)
Figure 27. Brazil Anaplastic Thyroid Cancer Market Size Growth 2020-2025 ($ millions)
Figure 28. APAC Anaplastic Thyroid Cancer Market Size Market Share by Region in 2024
Figure 29. APAC Anaplastic Thyroid Cancer Market Size Market Share by Type (2020-2025)
Figure 30. APAC Anaplastic Thyroid Cancer Market Size Market Share by Application (2020-2025)
Figure 31. China Anaplastic Thyroid Cancer Market Size Growth 2020-2025 ($ millions)
Figure 32. Japan Anaplastic Thyroid Cancer Market Size Growth 2020-2025 ($ millions)
Figure 33. South Korea Anaplastic Thyroid Cancer Market Size Growth 2020-2025 ($ millions)
Figure 34. Southeast Asia Anaplastic Thyroid Cancer Market Size Growth 2020-2025 ($ millions)
Figure 35. India Anaplastic Thyroid Cancer Market Size Growth 2020-2025 ($ millions)
Figure 36. Australia Anaplastic Thyroid Cancer Market Size Growth 2020-2025 ($ millions)
Figure 37. Europe Anaplastic Thyroid Cancer Market Size Market Share by Country in 2024
Figure 38. Europe Anaplastic Thyroid Cancer Market Size Market Share by Type (2020-2025)
Figure 39. Europe Anaplastic Thyroid Cancer Market Size Market Share by Application (2020-2025)
Figure 40. Germany Anaplastic Thyroid Cancer Market Size Growth 2020-2025 ($ millions)
Figure 41. France Anaplastic Thyroid Cancer Market Size Growth 2020-2025 ($ millions)
Figure 42. UK Anaplastic Thyroid Cancer Market Size Growth 2020-2025 ($ millions)
Figure 43. Italy Anaplastic Thyroid Cancer Market Size Growth 2020-2025 ($ millions)
Figure 44. Russia Anaplastic Thyroid Cancer Market Size Growth 2020-2025 ($ millions)
Figure 45. Middle East & Africa Anaplastic Thyroid Cancer Market Size Market Share by Region (2020-2025)
Figure 46. Middle East & Africa Anaplastic Thyroid Cancer Market Size Market Share by Type (2020-2025)
Figure 47. Middle East & Africa Anaplastic Thyroid Cancer Market Size Market Share by Application (2020-2025)
Figure 48. Egypt Anaplastic Thyroid Cancer Market Size Growth 2020-2025 ($ millions)
Figure 49. South Africa Anaplastic Thyroid Cancer Market Size Growth 2020-2025 ($ millions)
Figure 50. Israel Anaplastic Thyroid Cancer Market Size Growth 2020-2025 ($ millions)
Figure 51. Turkey Anaplastic Thyroid Cancer Market Size Growth 2020-2025 ($ millions)
Figure 52. GCC Countries Anaplastic Thyroid Cancer Market Size Growth 2020-2025 ($ millions)
Figure 53. Americas Anaplastic Thyroid Cancer Market Size 2026-2031 ($ millions)
Figure 54. APAC Anaplastic Thyroid Cancer Market Size 2026-2031 ($ millions)
Figure 55. Europe Anaplastic Thyroid Cancer Market Size 2026-2031 ($ millions)
Figure 56. Middle East & Africa Anaplastic Thyroid Cancer Market Size 2026-2031 ($ millions)
Figure 57. United States Anaplastic Thyroid Cancer Market Size 2026-2031 ($ millions)
Figure 58. Canada Anaplastic Thyroid Cancer Market Size 2026-2031 ($ millions)
Figure 59. Mexico Anaplastic Thyroid Cancer Market Size 2026-2031 ($ millions)
Figure 60. Brazil Anaplastic Thyroid Cancer Market Size 2026-2031 ($ millions)
Figure 61. China Anaplastic Thyroid Cancer Market Size 2026-2031 ($ millions)
Figure 62. Japan Anaplastic Thyroid Cancer Market Size 2026-2031 ($ millions)
Figure 63. Korea Anaplastic Thyroid Cancer Market Size 2026-2031 ($ millions)
Figure 64. Southeast Asia Anaplastic Thyroid Cancer Market Size 2026-2031 ($ millions)
Figure 65. India Anaplastic Thyroid Cancer Market Size 2026-2031 ($ millions)
Figure 66. Australia Anaplastic Thyroid Cancer Market Size 2026-2031 ($ millions)
Figure 67. Germany Anaplastic Thyroid Cancer Market Size 2026-2031 ($ millions)
Figure 68. France Anaplastic Thyroid Cancer Market Size 2026-2031 ($ millions)
Figure 69. UK Anaplastic Thyroid Cancer Market Size 2026-2031 ($ millions)
Figure 70. Italy Anaplastic Thyroid Cancer Market Size 2026-2031 ($ millions)
Figure 71. Russia Anaplastic Thyroid Cancer Market Size 2026-2031 ($ millions)
Figure 72. Egypt Anaplastic Thyroid Cancer Market Size 2026-2031 ($ millions)
Figure 73. South Africa Anaplastic Thyroid Cancer Market Size 2026-2031 ($ millions)
Figure 74. Israel Anaplastic Thyroid Cancer Market Size 2026-2031 ($ millions)
Figure 75. Turkey Anaplastic Thyroid Cancer Market Size 2026-2031 ($ millions)
Figure 76. Global Anaplastic Thyroid Cancer Market Size Market Share Forecast by Type (2026-2031)
Figure 77. Global Anaplastic Thyroid Cancer Market Size Market Share Forecast by Application (2026-2031)
Figure 78. GCC Countries Anaplastic Thyroid Cancer Market Size 2026-2031 ($ millions)